Navigation Links
Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.'s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan
Date:6/19/2008

RADNOR, Pa., June 19 /PRNewswire/ -- ADVERTISEMENT - The following statement was issued today by the law firm of Schiffrin Barroway Topaz & Kessler, LLP:

Schiffrin Barroway Topaz & Kessler, LLP is Co-Lead Counsel for the ERISA plaintiffs in the In re Merck & Co. Inc. Securities, Derivative, & ERISA Litigation, MDL No. 1658, pending in the U.S. District Court for the District of New Jersey. The Court recently ruled that claims for violations of the Employee Retirement Income Security Act of 1974 ("ERISA") relating to the failure of Merck & Co. Inc. ("Merck" or the "Company") (NYSE: MRK) to disclose material facts relating to Vytorin cannot be pursued as part of the ERISA action dealing with issues relating to Vioxx and should be pursued in a separate case. To date, lawsuits have been filed that allege that the investments in the Merck Common Stock Fund within the Merck & Co., Inc. Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, or the Merck Puerto Rico Employee Savings & Security Plan (collectively, the "Merck Plans") have declined substantially because Merck breached its fiduciary duties to participates of the Merck Plans when it failed to disclose material facts regarding Vytorin.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters and are or were a participant in the Merck & Co., Inc. Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, or the Merck Puerto Rico Employee Savings & Security Plan during the class period of April 1, 2006 through March 31, 2008, and were invested in the Merck Common Stock Fund, please contact Schiffrin Barroway Topaz & Kessler, LLP (Edward Ciolko, Esq. or Tiffany Melvin) toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at info@sbtklaw.com.

Specifically, the new suits allege that Merck breached its fiduciary duties under ERISA by failing to disclose to participants of the Merck Plans that the results of the ENHANCE trial showed no statistically significant difference between patient use of Vytorin versus patients treated with Simvastatin. When the results of ENHANCE trial of Vytorin were made public on March 28, 2008 both the Merck Plans and the Merck Plans' participants and beneficiaries suffered significant losses as Merck's stock price and the value of the Merck Common Stock Fund in the Merck Plans drastically decreased. Additionally, the new suits allege that Merck breached its fiduciary duties to prudently and loyally invest and maintain the assets of the Merck Plans and provide adequate information to the participants of those Merck Plans through its actions and omissions, including but not limited to its conduct in relation to Vytorin.

Schiffrin Barroway Topaz & Kessler, LLP is one of America's leading law firms handling ERISA retirement plan litigation. We are committed to helping employees and retirees protect their retirement savings.

If you are a member of the class, you may retain Schiffrin Barroway Topaz & Kessler, LLP, you may retain other counsel, do nothing, or take other steps to protect your rights.

Before making your choice of attorney, you should give this matter careful thought. The selection of an attorney is an important decision. For more information about Schiffrin Barroway Topaz & Kessler please visit http://www.sbtklaw.com.

CONTACT: Schiffrin Barroway Topaz & Kessler, LLP

Edward Ciolko, Esquire

Tiffany Melvin

280 King of Prussia Road

Radnor, PA 19087

1-888-299-7706 (toll free) or 1-610-667-7706

Or by e-mail at info@sbtklaw.com


'/>"/>
SOURCE Schiffrin Barroway Topaz & Kessler, LLP
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Shareholder Class Action Filed Against WellPoint, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
2. Shareholder Class Action Filed Against Candela Corporation by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Shareholder Class Action Filed Against Humana Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
4. Shareholder Class Action Filed Against NeuroMetrix Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
6. Shareholder Class Action Filed Against Health Management Associates, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. Shareholder Class Action Filed Against Medtronic, Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
9. NightHawk Radiology Holdings, Inc. Announces Final Results of Tender Offer; NightHawk Purchases 2,240,883 Shares of Its Common Stock at $8.05 per Share
10. Benda Pharmaceutical Announces Resignation of Board Member
11. Dilon Technologies Announces National Agreement with MedAssets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)...  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas ...
(Date:6/23/2016)... June 23, 2016  Experian Health, the ... transforming the patient payment and care experience, ... new products and services that will enhance ... cycle offerings. These award-winning solutions will enable ... remain compliant in an ever-changing environment and ...
Breaking Medicine Technology: